Ornisid

Орнисид Drug photo

The description is actual on 05.07.2016

  • Latin name: Ornisid
  • ATH code: G01AF06
  • Active ingredient: Ornidazol (Ornidazole)
  • Producer: Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. (Turkey)

Structure

Tabletsornidazol, potato starch, MKTs; magnesium stearate, hydroxymethylethyl cellulose.

Tablets vaginal — ornidazol, calcium dihydrophosphate, lactose, magnesium stearate, citric acid, PVP, starch corn kleysterizovanny.

Ornisid forte — ornidazol, MKTs, potato starch, magnesium stearate, a gipromeloza, water.

Release form

  • Tablets of 250 mg, round form, biconvex, white color, in the blister packaging No. 20 in a cardboard pack.
  • Tablets are vaginal, an oval form of 500 mg with the biconvex end, white color, in the blister packaging No. 3 in a cardboard pack.
  • Tablets Ornisid forte a round form, biconvex, 500 mg in the blister No. 10 in cardboard packaging.

Pharmacological action

Antibacterial, antiprotozoan.

Pharmacodynamics and pharmacokinetics

Pharmacodynamics

Drug with antiprotozoan effect and antibacterial activity. Recovers biochemical properties 5 of nitrogroup of an ornidazol which interacting with DNA of microorganisms, stops production of nucleic acids, causing their death.

Drug is highly active rather vaginal trichomonad, an intestinal lyambliya, an amoeba of a dysenteric, vaginal gardnerella, lyambliya; anaerobic microbacteria: gram-positive microorganisms. Aerobic microorganisms are not sensitive to drug.

Pharmacokinetics

Drug is quickly soaked up from a gastrointestinal tract. In blood the maximum concentration comes on average in two hours. Bioavailability of drug — 90%. Gets through GEB. Communication with blood proteins weak, about 15%. It is metabolized in a liver through biochemical reactions of a glyukuronirovaniye, hydroxylation and oxidation. 60-80% of volume in the form of metabolites with urine and 20-25% with a stake are removed. An elimination half-life — 14 hours.

Indications to use

Tablets Ornisid — treatment and prevention of trichomoniasis in urology; the infections caused by anaerobic activators at operations in gynecologic practice and on a colon, amoebic dysentery, an amebiasis, an abenteric amebiasis, a lambliasis.

Tablets vaginal — a nonspecific vaginitis, urogenital trichomoniasis.

Contraindications

High sensitivity to drug, diseases of TsNS of organic character, the pregnancy period (especially the I trimester) and lactations.

Side effects

Nausea, dizziness, diarrhea, headache, vomiting, tremor, ataxias, disturbance of consciousness, rigidity, spasms, peripheral neuropathy.

Ornisid, application instruction

Ornisid — to accept tablets inside, washing down with water.

  • At trichomoniasis — to accept the adult 2 times a day in a dosage 0,5 g for seven days; to children — once at the rate of a dose of 25 mg/kg.
  • At amoebic dysentery — to accept to adults and children weighing over 35 kg — in a dosage of 1,5 g once in day for three days.
  • At mephitic gangrenes to accept — 500 mg 2 times a day.
  • At an amebiasis of other forms to accept inside 0,5 g twice 7–10 days. Children are 7–12 years old a dose of 0,375 g;
  • At a lambliasis (adults and children weighing over 35 kg) — on 1,5 g once for 1–3 days.
  • Prevention of mephitic gangrenes — before and after operation on 1 g twice a day for 3–5 days.

Ornisid vaginal — to enter tablets deeply intravaginalno, having preposted hygienic procedure of generative organs.

At trichomoniasis — for the night in a dosage of 0,5 mg once a day or 1,5 g or in doses of 0,5 g twice a day or in a dose of 1 g once a day for five days are combined with reception of tablets inside once. At a nonspecific vaginitis which activator is the vaginal trichomonad treatment of the sexual partner the tableted forms is necessary. To stop sexual contacts during this period.

Overdose

Spasms are epileptiform, peripheral neuritis, depressions.

Interaction

Drug prolongs effect of muscular relaxation a bromide vekuroniya, strengthens effect of anticoagulants. Let's combine with alcohol.

Terms of sale

Prescription issue.

Storage conditions

At a temperature up to 30 °C.

Period of validity

24 months.

Ornisid's analogs

Gayro, Lornizol, Dazolik, Ornidazol-Vero, Ornidazol, Tiberal, Ornion.

About Ornisida

About drug in most cases positive. Drug is often appointed in complex therapy of various infectious diseases of the urogenital sphere.

  • "… In my analysis revealed a trichomonad and at the husband too. Ornisid (vaginal tablets) and Polizhinaks vaginalno, and to the husband — Ornisid in tablets appointed treatment, including vaginalno candles to 7 days. Were treated. Analyses good".

Zdravzona

  • Ornisid of 250 mg No. 20 tabletkiabdi Ibrahim
  • Ornisid forte 500 mg No. 10 tabletkiabdi Ibrahim
  • Ornisid of 500 mg No. 3 of a tablet vaginalnyeabdi Ibrahim
to show still

BIOSPHERE

  • Ornisid Forte of 500 mg No. 10 tabl.p.o.abdi Ibrahim (Turkey)
  • Ornisid of 250 mg No. 20 of table.
  • Ornisid of 500 mg No. 3 tabl.vag.abdi Ibrahim (Turkey)
to show still
Section: Gynecologic Antimicrobic
in more detail

Education: Graduated from Sverdlovsk medical school (1968 - 1971) as "Paramedic". Graduated from the Donetsk medical institute (1975 - 1981) as "An epidemiologist, a hygienist". Passed postgraduate study in the Central scientific research institute of epidemiology Moscow (1986 - 1989). An academic degree – the candidate of medical sciences (degree is awarded in 1989, protection – the Central scientific research institute of epidemiology Moscow). Numerous advanced training courses are studied in epidemiology and infectious diseases.

Experience: Work as the manager of department of disinfection and sterilization of 1981 - 1992. Work as the manager of department of especially dangerous infections of 1992 - 2010. Teaching activity at Medical institute 2010 - 2013.

PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before medicine use Ornisid surely consult with the attending physician.